Literature DB >> 3106737

Regulation of cell-mediated immunity in lepromatous leprosy.

G Kaplan, Z A Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3106737     DOI： 10.5935/0305-7518.19860072

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  7 in total

Review 1.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

Review 2.  Neutrophils in Leprosy.

Authors:  Veronica Schmitz; Isabella Forasteiro Tavares; Patricia Pignataro; Alice de Miranda Machado; Fabiana Dos Santos Pacheco; Jéssica Brandão Dos Santos; Camila Oliveira da Silva; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 3.  Offense and Defense in Granulomatous Inflammation Disease.

Authors:  Xinwen Wang; Yuan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-29       Impact factor: 6.073

4.  Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population.

Authors:  Furen Zhang; Hong Liu; Shumin Chen; Changyuan Wang; Chuanfu Zhu; Lin Zhang; Tongsheng Chu; Dianchang Liu; Xiaoxiao Yan; Jianjun Liu
Journal:  BMC Med Genet       Date:  2009-12-11       Impact factor: 2.103

5.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

6.  Novel HLA Class I Alleles Associated with Indian Leprosy Patients.

Authors:  U. Shankarkumar; K. Ghosh; S. Badakere; D. Mohanty
Journal:  J Biomed Biotechnol       Date:  2003

Review 7.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.